From Prototype to Profit: Commercialization Insights

The Italian football giant finalizes a new credit facility, solidifying RedBird Capital’s control and fueling a strategy for global growth and a new stadium.

A massive new logistics hub in Blue Island promises jobs and investment, aiming to reshape the local economy and bolster Chicago’s role in the US supply chain.

Spectral Medical shifts its FDA submission for a breakthrough sepsis device, a strategic move that could strengthen its case but delays a potential lifeline.

Facing soaring costs, hospitality operators are finding a lifeline in a flexible 'Rent-Try-Buy' equipment model that is fueling nationwide expansion.

With record SUBLOCADE revenue and a new U.S. home, Indivior launches a $400M buyback, signaling a new era in its fight against the opioid crisis.

The Kentucky Derby operator posts record revenue and operational earnings, yet a 28% drop in quarterly net income reveals a complex story of growth and challenges.

An AMA award for Sen. Julie Morrison highlights a new Illinois clinic that is revolutionizing care for young sexual assault survivors.

As Nicholas Bell heads to the Royal Ontario Museum, Melanie Kjorlien will steer Glenbow's landmark reopening and its pioneering free admission model.

Mahzi Therapeutics has dosed its first patient in a landmark study, offering a potential breakthrough for a rare and severe neurogenetic disorder.

All eyes are on Micron's March 18 report as a key test of the AI-fueled memory market recovery and the firm's strategic pivot to high-value tech.

Dallas-based Huitt-Zollars acquires San Diego's Vasquez Marshall Architects, a strategic move to dominate the lucrative federal design market in the region.

A massive new study finds ECGs save young lives, questioning UK policy as 12 die weekly from hidden heart conditions. Is repeat screening the answer?

Fastest-growing US professional skincare brand HYDRINITY partners with VeraSeaCosmetics, bringing its regenerative science to France's $5.4B beauty scene.

Digital workplace leader TeamViewer appoints enterprise veteran Tim Koubek to accelerate growth and capture a larger market share in the competitive Americas region.

As businesses struggle with unreliable AI, Collate launches a new platform to give models a deep understanding of enterprise data, aiming to build trust.

Intellia Therapeutics prepares for a critical March, where it will outline its gene editing future to investors amid safety questions and market pressures.

With pivotal data imminent for its blockbuster hopeful AXPAXLI, Ocular Therapeutix faces a critical month of investor meetings amid commercial headwinds.

The powertrain giant crushed market expectations with a 29% revenue surge in 2025, fueled by heavy-duty engines, while eyeing a global and green future.

A new Toronto building tackles the housing and childcare crises with a sustainable, community-led co-op model, setting a new standard for urban renewal.

Micromobility giant Dott reports its first-ever annual profit, fueling a massive 45,000-vehicle expansion and signaling a new era of sustainable growth.